1. Home
  2. ELTK vs IXHL Comparison

ELTK vs IXHL Comparison

Compare ELTK & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$8.31

Market Cap

53.3M

Sector

Technology

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.83

Market Cap

45.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
IXHL
Founded
1970
2001
Country
Israel
Australia
Employees
N/A
N/A
Industry
Electrical Products
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
53.3M
45.0M
IPO Year
1998
2024

Fundamental Metrics

Financial Performance
Metric
ELTK
IXHL
Price
$8.31
$3.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.7K
475.4K
Earning Date
05-19-2026
05-14-2026
Dividend Yield
2.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$0.11
52 Week High
$12.19
$6.39

Technical Indicators

Market Signals
Indicator
ELTK
IXHL
Relative Strength Index (RSI) 46.25 63.34
Support Level $7.79 $0.34
Resistance Level $9.34 $5.17
Average True Range (ATR) 0.37 0.30
MACD 0.03 0.04
Stochastic Oscillator 54.89 93.16

Price Performance

Historical Comparison
ELTK
IXHL

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: